Straits Times Index
3,337.86 +5.06 (+0.15%) Nikkei
39,614.42 +31.34 (+0.08%) Hang Seng
17,718.61 +2.11 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
63,212.11 +2,501.75 (+4.12%) CMC Crypto 200
1,313.74 +29.91 (+2.33%)
PTGX Oct 2024 17.500 call
| Previous close | 14.87 |
| Open | N/A |
| Bid | 11.50 |
| Ask | 15.00 |
| Strike | 17.50 |
| Expiry date | 2024-10-18 |
| Day's range | 14.87 - 14.87 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
PR NewswireProtagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
Insider MonkeyIs Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
Simply Wall St.We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation
Key Insights Protagonist Therapeutics to hold its Annual General Meeting on 20th of June Salary of US$655.2k is part of...
